Immune Diseases

Abstract

The recent identification of an increasing number of immune-mediated ataxias (IMA) highlights the potential for therapeutic interventions. However, the diagnosis of IMA remains challenging because there is significant phenotypic overlap with other forms of ataxia (genetic and degenerative). Furthermore, in the major-